FDA grants priority review to Genentech’s Inavolisib
The priority review is granted for advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
metastatic breast cancer treatment
BDR Pharma launches generic Palbociclib for breast cancer treatment
The drug will be made available in three strengths i.e. – 125 mg, 100 mg and 75 mg capsules priced at Rs 3,150 for 75 mg; Rs 3,600…